The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.
Pfizer and BioNTech Submit Data on Vaccine for Kids 5 to 11
Reviewed by Rucarys
on
September 28, 2021
Rating: 5
No comments